Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of CRISPR/Cas9-Mediated Fetal Hemoglobin Reactivation in Erythroblasts Derived from Cord Blood-Hematopoietic Stem Cells

22 Apr 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Hemoglobinopathies and Related Disorders
Share to Prenatal Screening and Diagnostics

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38649638
DOI: 10.1007/s12033-024-01155-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of CRISPR/Cas9-Mediated Fetal Hemoglobin Reactivation in Erythroblasts Derived from Cord Blood-Hematopoietic Stem CellsPMID 38649638Read ↗

CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell diseaseSemantic proximity Read ↗

Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted EndonucleasesSemantic proximity Read ↗

A cellular reporter system to evaluate endogenous fetal hemoglobin induction and screen for therapeutic compoundsSemantic proximity Read ↗

Safety and efficacy studies of CRISPR-Cas9 treatment of sickle cell disease highlights disease-specific responsesSemantic proximity Read ↗

Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocationsSemantic proximity Read ↗

CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cellsSemantic proximity Read ↗

Safety and efficacy study of CRISPR/Cas9 treatment of sickle cell disease in clinically relevant conditions highlights disease-specific responseSemantic proximity Read ↗

The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies.Semantic proximity Read ↗

CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantationSemantic proximity Read ↗

Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies.Semantic proximity Read ↗

Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34 <sup>+</sup> cell therapy to induce fetal hemoglobin for sickle cell diseaseSemantic proximity Read ↗

CRISPR medicine for blood disorders: Progress and challenges in deliverySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.